GT BIOPHARMA, INC.
P/E (Price-to-Earnings)
Price
EPS
P/E (Price-to-Earnings)
| Fiscal Year | P/E (Price-to-Earnings) | EPS | Price |
|---|---|---|---|
| Sep 2018 | 0.00x | $41,159.99 | $0.27 |
| Dec 2019 | 65.54x | $0.04 | $2.30 |
| Mar 2020 | 353.54x | $0.03 | $12.01 |
| Dec 2025 | 6.43x | $0.13 | $0.81 |
P/E (Price-to-Earnings)
Price
EPS
P/E (Price-to-Earnings)
| Fiscal Year | P/E (Price-to-Earnings) | EPS | Price |
|---|---|---|---|
| Sep 2018 | 0.00x | $41,159.99 | $0.27 |
| Dec 2019 | 65.54x | $0.04 | $2.30 |
| Mar 2020 | 353.54x | $0.03 | $12.01 |
| Dec 2025 | 6.43x | $0.13 | $0.81 |